Menu

Theme

Privacy Policy Terms of Service

MASLD / MASH

17 lectures

Cirrhosis Reversal: The Sprint is Not Over Yet!

Cirrhosis Reversal: The Sprint is Not Over Yet!

Prof. Meena Bansal

June 23, 2026

Management of MASH: Best Practices

Management of MASH: Best Practices

Prof. Arun Sanyal

April 26, 2026

INEDCAST- Q&A session on Revised NAFLD Nomenclature with Prof (Dr). Mary Rinella

INEDCAST- Q&A session on Revised NAFLD Nomenclature with Prof (Dr). Mary Rinella

Prof. Mary Rinella

March 17, 2026

Bridging Histology and Technology in Liver Disease

Bridging Histology and Technology in Liver Disease

Dr. David Kleiner

May 17, 2025

Noninvasive Evaluation of Hepatic Steatosis, Inflammation, and Fibrosis

Upgrade to view

Noninvasive Evaluation of Hepatic Steatosis, Inflammation, and Fibrosis

Prof. Vincent Wong

March 22, 2025

INEDCAST: Q&A Session with Dr. Anil Arora on the Pathogenesis of Hepatic Steatosis

INEDCAST: Q&A Session with Dr. Anil Arora on the Pathogenesis of Hepatic Steatosis

Prof. Anil Arora

November 24, 2024

INEDCAST: Q&A session on MASLD and Sarcopenia with Prof. Zobair Younossi.

INEDCAST: Q&A session on MASLD and Sarcopenia with Prof. Zobair Younossi.

Prof. Zobair M Younossi

November 10, 2024

Pathogenesis of Hepatic Steatosis: Insights into Potential Treatment Options

Upgrade to view

Pathogenesis of Hepatic Steatosis: Insights into Potential Treatment Options

Prof. Anil Arora

September 30, 2024

MASLD and Sarcopenia

Upgrade to view

MASLD and Sarcopenia

Dr. Zobair Younossi, MD

September 15, 2024

Management of Alcohol Associated Liver Diseases: Review of Current Guidelines

Management of Alcohol Associated Liver Diseases: Review of Current Guidelines

Dr. Ashwani K. Singal, MD

March 26, 2024

Revised NAFLD Nomenclature: Global Consensus for Enhanced Clarity and Precision

Revised NAFLD Nomenclature: Global Consensus for Enhanced Clarity and Precision

Dr. Mary Rinella, MD

November 5, 2023

Emerging Therapeutic Approaches for Metabolic Dysfunction Associated Steatotic Liver Disease

Emerging Therapeutic Approaches for Metabolic Dysfunction Associated Steatotic Liver Disease

Dr. Mazen Noureddin, MD, MHSc

October 8, 2023

Risk and Outcomes of DILI in Patients with Underlying Liver Disease

Risk and Outcomes of DILI in Patients with Underlying Liver Disease

Prof. Naga Chalasani

April 23, 2023

The Management of NASH: What Does the Future Hold?

The Management of NASH: What Does the Future Hold?

Dr. Naim Alkhouri

March 11, 2023

NAFLD vs. MAFLD: The Good, the Bad and the Ugly

NAFLD vs. MAFLD: The Good, the Bad and the Ugly

Prof. S.P. Singh

September 18, 2022

Pathogenesis and Treatment of Hepatic Fibrosis: Is Reversal of Cirrhosis a Myth?

Pathogenesis and Treatment of Hepatic Fibrosis: Is Reversal of Cirrhosis a Myth?

Dr. Meena Bansal

August 16, 2022

Non-Invasive Diagnosis of Liver Fibrosis: An Update

Non-Invasive Diagnosis of Liver Fibrosis: An Update

Dr. Shadab Anwar

October 30, 2021